PUT - SPRINTER OPEN END - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 18:51:06 31/05/2024 BST | ||
| 3.39 EUR | -1.17% |
|
| 1 month | +9.35% | ||
| 3 months | +33.99% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 3.39 | -1.17% |
| 30/05/24 | 3.43 | -0.58% |
| 29/05/24 | 3.45 | +0.58% |
| 28/05/24 | 3.43 | +2.69% |
| 27/05/24 | 3.34 | +0.30% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 06:51 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| WKN | VU0QS8 |
| ISIN | DE000VU0QS82 |
| Date issued | 12/12/2022 |
| Strike | 77.77 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.07 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.48 € |
|---|---|
| Lowest since issue | 0.065 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.09
USD
Average target price
53.19
USD
Spread / Average Target
+29.46%
- Stock Market
- Certificates
- Certificat
